Back
ALX Oncology Holdings Vs. Verve Therapeutics Industry Stock Comparison
Sell
34
ALXO
ALX Oncology Holdings
Last Price:
1.50
Seasonality Move:
30.31%
Sell
1
VERV
Verve Therapeutics
Last Price:
6.04
Seasonality Move:
-35.34%
Sell
34
ALX Oncology Holdings (ALXO)
is a Sell
Is ALX Oncology Holdings a Buy, Sell or Hold?
- The current ALX Oncology Holdings [ALXO] share price is $1.49. The Score for ALXO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- ALXO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy, Sell or Hold?
- The current Verve Therapeutics [VERV] share price is $6.04. The Score for VERV is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- VERV is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ALXO Stock Price Chart
What is ALX Oncology Holdings's stock price today?
-
The ALX Oncology Holdings share price today is $1.49
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALXO is experiencing slight selling pressure.
VERV Stock Price Chart
What is Verve Therapeutics's stock price today?
-
The Verve Therapeutics share price today is $6.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VERV is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALXO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 40.69 | Sell |
| Chaikin Money Flow: | -87896 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.43 - 1.69) | Sell |
| Bollinger Bands (100): | (1.34 - 5.84) | Sell |
VERV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 62.69 | Buy |
| Chaikin Money Flow: | 412752 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ALXO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.44 | Buy |
| 20-day SMA: | 1.51 | Sell |
| 50-day SMA: | 1.85 | Sell |
| 200-day SMA: | 8.7 | Sell |
| 8-day EMA: | 1.46 | Buy |
| 20-day EMA: | 1.55 | Sell |
| 50-day EMA: | 2.2 | Sell |
| 200-day EMA: | 6.32 | Sell |
VERV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.89 | Buy |
| 20-day SMA: | 5.45 | Buy |
| 50-day SMA: | 5.41 | Buy |
| 200-day SMA: | 7.73 | Sell |
| 8-day EMA: | 5.85 | Buy |
| 20-day EMA: | 5.6 | Buy |
| 50-day EMA: | 5.51 | Buy |
| 200-day EMA: | 7.68 | Sell |
ALX Oncology Holdings Earnings Growth & ALXO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and an increase next year of $0.24 per share.
Verve Therapeutics Earnings Growth & VERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.28 per share.
ALX Oncology Holdings Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Verve Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||